Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
migraine
Pharma
Teva's innovative drugs helped carry strong Q1
Teva topped Wall Street estimates in 2026’s first quarter, buoyed by the impressive performance of branded drugs like Austedo, Uzedy and Ajovy.
Fraiser Kansteiner
Apr 29, 2026 2:27pm
In Lilly patent spat, appeals court revives $177M verdict to Teva
Apr 17, 2026 10:16am
AbbVie has ‘Love in Mind’ with new migraine educational campaign
Feb 2, 2026 12:33pm
Lundbeck stays positive on Rexulti PTSD use despite adcomm vote
Aug 15, 2025 10:50am
Teva forecasts $5B-plus in innovative drug sales by 2030
May 30, 2025 7:20am
Axsome secures hard-fought FDA nod for migraine drug Symbravo
Jan 31, 2025 8:18am
